BACKGROUND The aim of this study is to assess differences in human chorionic
gonadotropin (hCG) values between singleton IVF/ICSI pregnancies after elective single …

OBJECTIVE: To compare β-hCG levels measured as the first pregnancy test in women who
conceived after in vitro maturation (IVM) or IVF. DESIGN: Retrospective matched cohort …

OBJECTIVE: To review the use of hCG and to describe the clinical benefit of recombinant
hCG (r-hCG) based on the published results of prospective, randomized studies. DESIGN …

The pharmacokinetics of human chorionic gonadotropin (hCG) was studied in 15 normal
volunteers and 15 patients undergoing in vitro fertilization (IVF). Each subject received 6000 …

To assess successful implantation and early post-implantation embryonic development in
assisted reproduction techniques, serum human chorionic gonadotropin (hCG) levels in …

Objective: To determine the predictive value (s) of β–hCG serum levels for pregnancy
outcome following blastocyst transfer. Design: Retrospective review. Setting: University …

The current study assessed the relationship between serum concentrations of human
chorionic gonadotrophin (HCG) measured in the peri-implantation period and various …

OBJECTIVE: To compare the effectiveness of urinary human chorionic gonadotropin (u-
hCG) at reduced doses of 4000IU and 6000IU in inducing final oocyte maturation during in …

OBJECTIVE: To identify determinants of the serum concentration of hCG levels after
triggering of ovulation with exogenous hCG during controlled ovarian stimulation cycles for …

Objectives: Providers often elect to administer 5000 IU of hCG rather than 1000 IU as an LH
surrogate during IVF in efforts to decrease ovarian hyperstimulation syndrome (OHSS) in …